Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase

Fig. 5

Effects of HJNO and MMC on the ultraviolet aborption of BLM helicase. a Effects of different concentration of HJNO on the ultraviolet absorption spectrum of BLM helicase (500 nM). b Effects of HJNO (0.1 μmol/L, 5 μmol/L, 50 μmol/L) on the ultraviolet absorption spectrum of BLM helicase (500 nM). c Effects of different concentration of MMC on the ultraviolet absorption spectrum of BLM helicase (500 nM). d Effects of MMC (0.1 μmol/L, 5 μmol/L, 50 μmol/L) on the ultraviolet absorption spectrum of BLM helicase (500 nM)

Back to article page